Over the past three months, congress has sold over $66K dollars worth of UnitedHealth Group UNH stock. A total of 3 transactions have taken place by 3 different congressional members with Daniel Goldman selling the most, totaling $50,001.00 worth of UNH stock.
Congressional Transactions for UNH Over Past 3 Months
Member Name | Chamber | Symbol | Company | Transaction Date | Transaction Type | Amount |
---|---|---|---|---|---|---|
Daniel Goldman | UNH | UnitedHealth Group | House | 2023-03-06 | S (Partial) | $50,001.00 |
John Curtis | UNH | UnitedHealth Group | House | 2023-02-23 | S (Partial) | $1,001.00 |
Scott Franklin | UNH | UnitedHealth Group | House | 2023-02-15 | S (Partial) | $15,001.00 |
Given the recent sell-side activity from congressional members, it leads one to question UnitedHealth Group's future. First let's look at how UnitedHealth Group has been performing recently.
As you can see, despite the recent sell-off by members of Congress, UnitedHealth Group has performed well over the past three months, achieving a 2.73% return.
Recap
Over the past three months, 3 congressional members have sold over $66K dollars worth of UnitedHealth Group stock, while the stock has gained 2.73% over the same timeframe.
The recent sell-side activity by congress could be a result of members capitalizing on gains if they believe the current trend will not continue. On the other hand, congressional members can sell stock for a variety of reasons, including personal financial needs or diversification of their investment portfolios, so it's important to keep a balanced perspective and look at the company's performance holistically.
As always, investors should conduct their due diligence and consider other factors, such as a company's financials, analyst ratings, and broader market trends, before making any investment decisions.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.